PhD students, postdocs, and early-career biomedical researchers: Learn how to turn your research into real patient benefits!
The World Drug Safety Congress offers the perfect setting to address how to drive pharmacovigilance operations forward for industry professionals, international regulatory bodies and academic representatives.
Este artículo aborda la innovación en el campo de la Farmacovigilancia (FV) mediante la implementación de técnicas avanzadas de automatización y aprendizaje automático en las búsquedas bibliográficas, un proceso crucial para garantizar la seguridad de los medicamentos.
Are you prepared for the regulatory changes coming in 2025? These changes could significantly impact your budget
This guidance recommends steps manufacturers and applicants of active pharmaceutical ingredients (APIs) and drug products should take to detect and prevent unacceptable levels of nitrosamine impurities in drug products. The guidance also describes conditions that may introduce nitrosamine impurities. The unexpected finding of nitrosamine impurities, which are probable or possible human carcinogens, in certain drug products has made clear the need for a risk assessment strategy for the potential presence of nitrosamines in any drug product.
The MHRA has issued a new guidance on the implementation of the Windsor Framework. This new guidance
Preparing and submitting an Investigational Medicinal Product Dossier (IMPD) is a crucial step in the drug development
Search or filter
Services
Memberships & Partnerships
Quality Management System
SDGs
As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.
© Asphalion
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
